Illuminating Parkinson's therapy with optogenetics
- 6 February 2015
- journal article
- editorial
- Published by Springer Nature in Nature Biotechnology
- Vol. 33 (2) , 149-150
Abstract
Controlling transplanted dopamine neurons with light helps define their mechanism of action.Keywords
This publication has 10 references indexed in Scilit:
- Optogenetics enables functional analysis of human embryonic stem cell–derived grafts in a Parkinson's disease modelNature Biotechnology, 2015
- DREADDs (Designer Receptors Exclusively Activated by Designer Drugs): Chemogenetic Tools with Therapeutic UtilityAnnual Review of Pharmacology and Toxicology, 2015
- Chemogenetic Tools to Interrogate Brain FunctionsAnnual Review of Neuroscience, 2014
- Optical Control of Muscle Function by Transplantation of Stem Cell–Derived Motor Neurons in MiceScience, 2014
- Human embryonic stem cell-derived neurons adopt and regulate the activity of an established neural networkProceedings of the National Academy of Sciences, 2011
- Functional Control of Transplantable Human ESC-Derived Neurons Via Optogenetic TargetingStem Cells, 2010
- Remote Control of Neuronal Activity in Transgenic Mice Expressing Evolved G Protein-Coupled ReceptorsNeuron, 2009
- Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligandProceedings of the National Academy of Sciences, 2007
- Millisecond-timescale, genetically targeted optical control of neural activityNature Neuroscience, 2005
- Dopaminergic Modulation of Excitatory Postsynaptic Currents in Rat Neostriatal NeuronsJournal of Neurophysiology, 1997